companydata.dkcompanydata.dk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2016

CVR: 33242840

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 23,570,140 and a net result of DKK 1,162,789 compared with DKK 459,045 the year before. That is an increase of 144.9% compared with the year before. Equity in the 2016 report amounted to DKK 2,467,306. The solvency ratio was 38.3%.

Gross Profit
DKK 23,570,140
Profit/Loss
DKK 1,162,789
Equity
DKK 2,467,306
Total Assets
DKK 6,442,081

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-23.6M1.2M2.5M-
2015-9.6M459K1.3M-
2014-4.8M299K845K-
2013-3.8M238K546K-
2012-2.2M145K308K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: The 2015 annual report is outJul 1, 2016

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2015. Gross profit came to DKK 9,625,172, and the net result was DKK 459,045.

About PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.

Source: annual report 2025, Danish Business Authority